查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球蛋白質標記市場
市場調查報告書
商品編碼
1176603

2023-2030 年全球蛋白質標記市場

Global Protein Labeling Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期內 (2023-2030)，全球蛋白質標記市場規模預計將以 6.4% 的複合年增長率增長。

生物學研究需要使用與目標蛋白質共價結合的分子信標，以促進標記蛋白質及其結合夥伴的純化或檢測。 蛋白質標記的主要目標是監測生物過程、化合物的可靠定量、多重樣品中蛋白質修飾和亞型的特異性檢測、提高檢測靈敏度以及簡化檢測工作流程。。

市場動態

推動全球蛋白質標記市場發展的主要因素是全球慢性病患病率上升、研發成本上升以及生物技術技術的採用。 越來越多的新產品發布正在促進蛋白質標記市場的增長。

基因組測序、蛋白質組學研究的興起以及先進生物工程技術的採用有望推動市場增長。

越來越多地採用這些蛋白質標記產品進行生物學和正常細胞功能研究中的翻譯後修飾研究，越來越多地採用先進的生物工程技術在各種技術中，例如癌症慢性病的流行和診斷需求的增加正在推動蛋白質標記市場。 世界上慢性病的增加也推動了市場的增長。 此外，許多醫療保健公司正在加緊研發活動以開發新產品。

蛋白質印跡、ELISA、免疫組織化學、免疫細胞化學和流式細胞術等檢測方法需要用於醫學和臨床研究的各種蛋白質標記方法。 市場上有多種標籤供多種用途使用，每次使用時都應仔細選擇要使用的名稱類型和標籤策略。 對基因組測序和蛋白質組學研究的需求激增正在推動市場增長。 此外，主要參與者對新型疫苗和技術先進產品的研究和開發不斷增加，預計也將在市場增長中發揮重要作用。

各種新產品的發布、監管批准和研究都為市場的增長做出了貢獻。 例如，2021年9月17日，PerkinElmer宣布已完成對生命科學試劑和抗體供應商BioLegend的收購，總收購價格約為52.5億美元。 此次收購將 PerkinElmer 的生命科學業務擴展到高增長領域，如蛋白質組學、細胞計數、多重分析、磁性細胞分離、重組蛋白和生物加工。

預計熟練專業人員的數量有限會阻礙市場的增長。

然而，在當前情況下，熟練專業人員的可用性有限、主要參與者之間為推出先進產品而展開的競爭加劇以及產品的使用有限可能會阻礙市場增長。

此外，蛋白標記的高成本也是抑制生長的一大因素。 化學標記的缺點是修飾的蛋白質失去了一種或多種活性。 因此，應針對未標記的蛋白質測試標記蛋白質的活性。 此外，代謝標記需要純化放射性蛋白，長期使用低溫恆溫器和離心機使得難以建立放射性。

COVID-19 影響分析

疫情對全球金融預期、運營和危機應對策略產生了負面影響。 COVID-19 的爆發嚴重影響了醫療保健行業。 由於 COVID 患者的增加，各種研究和臨床試驗被推遲，蛋白質標記市場因 COVID 遭受了巨大損失。 世界各地正在發生各種舉措、產品發布、創新、合作和合併，推動了市場的增長。 例如，2021年7月28日，Promega公司宣布美國FDA批准了Promega OncoMate MSI Dx分析系統。 美國病理學家和腫瘤學家可以使用微衛星不穩定性 (MSI) 診斷來篩查結直腸癌患者是否患有 Lynch 綜合徵。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 基因組測序和蛋白質組學研究的興起
      • 更多地採用先進的生物工程技術
    • 約束因素
      • 缺乏熟練的專業人員
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 定價分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 工具包
  • 試劑
    • 探測標籤
    • □
    • 生物素
    • 其他
  • 服務

第 8 章按符號類型

  • 體外標籤
  • 體內標記
  • 生物正交標記

第 9 章按應用

  • 基於細胞的分析
  • 免疫技術
  • 蛋白質微陣列
  • 質譜
  • 熒光顯微鏡

第 10 章最終用戶

  • 醫院
  • 研究所
  • 診斷中心
  • 其他

第11章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第12章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 值得關注的主要公司名單

第13章公司簡介

  • Thermo Fisher Scientific
    • 公司概況
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Merck KGaA
  • PerkinElmer Inc.
  • GE Healthcare
  • Qiagen N.V.
  • New England Biolabs
  • SeraCare Life Sciences Inc.
  • Promega Corporation
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies

第14章 DataM

簡介目錄
Product Code: DMBT820

Market Overview

The global protein labeling market size was valued at US$ XX mill-ion in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 6.4% during the forecast period (2023-2030).

Biological research requires the use of molecular labels that are covalently attached to a protein of interest to facilitate the purification or detection of the labeled protein and its binding partners. The primary purpose of protein labeling is monitoring the biological process, reliable quantification of compounds, specific detection of protein modifications and isoforms in multiplexed samples, enhancement of detection sensitivity, and simplification of detection workflows.

Market Dynamics

The major factors driving the global protein labeling market are an increase in the number of chronic diseases globally, rising research and development expenditure and the adoption of bioengineering techniques. An increase in novel product launches contributes to the growth of the protein labeling market.

The rising genome sequencing and proteomics research and adoption of sophisticated bioengineering techniques are expected to drive the market's growth.

The rising adoption of these protein labeling products for post-translational modification studies in the investigation of biological functions as well as normal cell functioning, the rising adoption of sophisticated bioengineering techniques in various technologies, and the growth in the prevalence of chronic diseases such as cancer and the need for diagnosis drive the protein labeling market. An increase in chronic diseases globally is also aiding market growth. There has been an increase in R&D activities by many healthcare companies to develop novel products.

Test that includes western blotting, ELISA, immunohistochemistry, immunocytochemistry, and flow cytometry requires protein labeling methods for various medical and clinical studies. There is an availability of multiple labels in the market for multiple applications, and the type of name and labeling strategy used must be carefully selected for each application. The surge in demand for genome sequencing and proteomics research is fueling the market's growth. Moreover, the increase in research and development of novel vaccines and the availability of technologically advanced products by key players are also expected to play a vital role in the market's growth.

Various novel product launches, regulatory approvals and research studies contribute to the market's growth. For instance, in September 17, 2021, PerkinElmer, Inc. announced its completion of the acquisition of BioLegend, a life science reagents and antibodies provider, for approximately $5.25 billion in total consideration. This acquisition expands the life science franchise of PerkinElmer into high-growth areas like proteogenomics, cytometry, multiplex assays, magnetic cell separation, recombinant proteins and bioprocessing.

The skillful professional's limited availability is expected to hamper the market's growth.

However, the limited availability of skillful professionals in the current scenario, increased competition among key players for launching advanced products, and limited product applications may hinder the growth of the market.

The high cost of protein labeling is also a leading factor for restrained growth, as chemical labeling has a drawback that the protein that has been modified can lose one or more activities. So, the labeled protein's activity should be tested relative to unlabeled protein. Metabolic labeling also needs purification of the radioactive protein, and over the extended use of cold room equipment and centrifuges, it is difficult to consist the radioactivity.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The protein labeling market has experienced huge losses due to COVID, as various research and clinical trials got postponed due to the increasing number of COVID cases. Various initiatives, product launches, innovations, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in July 28, 2021, Promega Corporation announced that U.S. FDA had cleared its Promega OncoMate MSI Dx Analysis System. Pathologists and oncologists in the US can utilize microsatellite instability (MSI) diagnostic for screening Lynch syndrome in colorectal cancer patients.

Segment Analysis

The reagent segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The reagent segment is the highest market holder in the global protein labeling market. The global protein labeling market is segmented based on product type as kits, reagents and services. The reagents segment is the largest market shareholder due to its high demand and usage, increasing prevalence of cancer and rising adoption of these for protein labeling products. Reagents are further sub-segmented into probes, biotin, proteins, enzymes and others. These reagents hold the largest market share due to increased demand for peptide-binding agents and increased research and development activities, which are expected to remain high during the forecast period.

The protein labeling reagents are developed to label target proteins selectively. These products are classic dyes, biotinylation reagents, radioisotope labels, fluorescent labels, assays, molecular probes, and labeling kits. Fluorophores, stable isotopes, and mass tags are three important tags implemented during protein labeling. Western blotting, immunohistochemistry, ELISA, immunocytochemistry, and flow cytometry require protein labeling methods for various medical and clinical studies. There is an availability of multiple labels in the market for multiple applications, and the type of name and labeling strategy used must be carefully selected for each application.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in July 28, 2021, PerkinElmer, Inc announced the launch of its four-novel ready-to-use AlphaLISA KRAS kits, developed to provide scientists with a better understanding of complex KRAS protein structures as well as mutations so that potential new therapeutic candidates identification gets more easy, precise and quick for a broad range of prevalent cancers.

Geographical Analysis

North America holds the largest market share in the global protein labeling market.

North America dominates the global protein labeling market, primarily due to its large population, excellent medical infrastructure, and rising number of chronic diseases like cancer. The market is expected to grow at a relatively high pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of products for various applications, including cell-based assay, immunological techniques, mass spectroscopy, protein microarrays, fluorescence microscopy, increase in pharmaceutical establishment across the region, government approvals, and key players in the region are contributing to the growth of the protein labeling market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, regulatory approvals, technological advancements, collaborations, and agreements are taking place in this region. For instance, in January 11, 2022, Merck, a science and technology company, announced its Stable Isotope Center of Excellence expansion in Miamisburg, Ohio. The expansion strengthens the continued commitment of the company to this product category, which shows growing utility in industrial, diagnostic and research applications.

Competitive Landscape

The protein labeling market is moderately competitive with local and global companies' presence. Thermo Fisher Scientific, Merck KGaA, PerkinElmer Inc., GE Healthcare, Qiagen N.V., New England Biolabs, SeraCare Life Sciences Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Agilent Technologies and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in June 7, 2021, Thermo Fisher Scientific announced its agreement with Advanced Electrophoresis Solutions Ltd (AES), protein imaging technologies specialists, to combine mass spectrometry (MS) with essential protein separation techniques for the advancement of therapeutic protein development via streamlined characterization.

Thermo Fisher Scientific.

Overview: This is a company that supplies a variety of scientific or analytical instruments, lab reagents & consumables, and some scientific software services. It was founded in 1956 and headquartered in Waltham, Massachusetts, U.S.

Product Portfolio:

Fluorescent Protein Labeling Kits: The fluorescent dye attachment to proteins or other biomolecules is a general strategy used to better understand protein function and structure. These fluorescent proteins can be utilized in various applications, like immunochemistry, receptor labeling, cell tracing and fluorescence spectroscopy.

Key Developments: In October 31, 2022, Thermo Fisher Scientific Inc. announced entering into a definitive acquisition agreement with The Binding Site Group, a specialty diagnostics company that provides specialized diagnostic instruments and assays, from a group of shareholders led by Nordic Capital, a European private equity firm.

The global protein labeling market report would provide access to approx.: 45+ market data tables, 40+ figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising genome sequencing and proteomics research
      • 4.1.1.2. Increasing adoption of sophisticated bioengineering techniques
    • 4.1.2. Restraints:
      • 4.1.2.1. Limited availability of skillful professionals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Kits *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Reagents
    • 7.3.1. Probes/ Tags
    • 7.3.2. Enzyme
    • 7.3.3. Biotin
    • 7.3.4. Others
  • 7.4. Services

8. By Labeling Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Labeling Type
    • 8.1.2. Market Attractiveness Index, By Labeling Type
  • 8.2. In-Vitro Labeling *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. In-Vivo Labeling
  • 8.4. Bio-orthogonal Labeling

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Cell-Based Assay *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Immunological Techniques
  • 9.4. Protein Microarrays
  • 9.5. Mass Spectroscopy
  • 9.6. Fluorescence Microscopy

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Research laboratories
  • 10.4. Diagnostic centers
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Labeling Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Labeling Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Labeling Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Labeling Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Labeling Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Thermo Fisher Scientific *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Merck KGaA
  • 13.3. PerkinElmer Inc.
  • 13.4. GE Healthcare
  • 13.5. Qiagen N.V.
  • 13.6. New England Biolabs
  • 13.7. SeraCare Life Sciences Inc.
  • 13.8. Promega Corporation
  • 13.9. Bio-Rad Laboratories, Inc.
  • 13.10. Agilent Technologies

LIST NOT EXHAUSTIVE

14. Global Protein Labeling Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and End-User
  • 14.3. Contact Us